Form 483

Nowcos Co., Ltd. Form 483, 2026-06-19

FDA issued a Form 483 to Nowcos Co., Ltd. on 2026-06-19 with 6 public-safe observations.

483· Form 483 issuedHuman Drugs6 observations

Nowcos Co., Ltd. · Sejong, Korea (the Republic of) · Issued June 19, 2026

Overview

  • 6 public-safe observations are available for this inspection.
  • 6 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

19 Jun 2026
21 CFR 211.165(e)

Test methods

Cited by Lisa R Hilliard

19 Jun 2026
21 CFR 211.166(a)

Written program not followed

Cited by Lisa R Hilliard

19 Jun 2026
21 CFR 211.188

Prepared for each batch, include complete information

Cited by Lisa R Hilliard

19 Jun 2026
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Lisa R Hilliard

19 Jun 2026
21 CFR 211.67(b)

Written procedures not established/followed

Cited by Lisa R Hilliard

Inspected site

NCNowcos Co., Ltd.Sejong, Korea (the Republic of)

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.165(e)Cited across public-safe Form 483 observations1x
21 CFR 211.166(a)Cited across public-safe Form 483 observations1x
21 CFR 211.188Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x
21 CFR 211.84(a)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 6 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere